These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3871512)

  • 1. Active clearance of corticotropin-releasing factor from the cerebrospinal fluid.
    Oldfield EH; Schulte HM; Chrousos GP; Rock JP; Kornblith PL; O'Neill DL; Poplack DG; Gold PW; Cutler GB; Loriaux L
    Neuroendocrinology; 1985 Jan; 40(1):84-7. PubMed ID: 3871512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis.
    Rock JP; Oldfield EH; Schulte HM; Gold PW; Kornblith PL; Loriaux L; Chrousos GP
    Brain Res; 1984 Dec; 323(2):365-8. PubMed ID: 6335410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm.
    Garrick NA; Hill JL; Szele FG; Tomai TP; Gold PW; Murphy DL
    Endocrinology; 1987 Oct; 121(4):1329-34. PubMed ID: 3498627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates.
    Strome EM; Wheler GH; Higley JD; Loriaux DL; Suomi SJ; Doudet DJ
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15749-54. PubMed ID: 12438692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
    Suda T; Tozawa F; Mouri T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):225-6. PubMed ID: 6602142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing.
    Mathew SJ; Coplan JD; Smith EL; Scharf BA; Owens MJ; Nemeroff CB; Mann JJ; Gorman JM; Rosenblum LA
    Stress; 2002 Sep; 5(3):185-93. PubMed ID: 12186681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations.
    Coplan JD; Smith EL; Trost RC; Scharf BA; Altemus M; Bjornson L; Owens MJ; Gorman JM; Nemeroff CB; Rosenblum LA
    Psychiatry Res; 2000 Aug; 95(2):93-102. PubMed ID: 10963795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor and behavior.
    Koob GF; Bloom FE
    Fed Proc; 1985 Jan; 44(1 Pt 2):259-63. PubMed ID: 3871412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.
    McLean SA; Williams DA; Stein PK; Harris RE; Lyden AK; Whalen G; Park KM; Liberzon I; Sen A; Gracely RH; Baraniuk JN; Clauw DJ
    Neuropsychopharmacology; 2006 Dec; 31(12):2776-82. PubMed ID: 16936702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N; Suda T; Tozawa F; Demura H; Shizume K; Mouri T
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1305-7. PubMed ID: 6605358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm.
    Ayala AR; Pushkas J; Higley JD; Ronsaville D; Gold PW; Chrousos GP; Pacak K; Calis KA; Gerald M; Lindell S; Rice KC; Cizza G
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5729-37. PubMed ID: 15531536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat.
    Rivier C; Vale W
    Endocrinology; 1984 Jun; 114(6):2409-11. PubMed ID: 6609812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
    Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M
    J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system.
    Udelsman R; Harwood JP; Millan MA; Chrousos GP; Goldstein DS; Zimlichman R; Catt KJ; Aguilera G
    Nature; 1986 Jan 9-15; 319(6049):147-50. PubMed ID: 3001536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    Biol Psychiatry; 1996 Apr; 39(8):703-7. PubMed ID: 8731457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus.
    Parkes D; Rivest S; Lee S; Rivier C; Vale W
    Mol Endocrinol; 1993 Oct; 7(10):1357-67. PubMed ID: 8264665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced lumbar cerebrospinal fluid corticotropin releasing factor (CRF) levels in amyotrophic lateral sclerosis.
    Klimek A; Cieślak D; Szulc-Kuberska J; Stepien H
    Acta Neurol Scand; 1986 Jul; 74(1):72-4. PubMed ID: 3490112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.